HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Koh Takeuchi Pedro J. del Nido Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Takeuchi, K. Articles by del Nido, P. J. Search for Related Content PubMed PubMed Citation Articles by Takeuchi, K. Articles by del Nido, P. J.

Ann Thorac Surg 1999;68:903-907
© 1999 The Society of Thoracic Surgeons

---

Original Articles: Cardiovascular

Prolonged preservation of the blood-perfused canine heart with glycolysis-promoting solution

^a Department of Cardiac Surgery, Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USA
^b Department of Anesthesiology, Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USA
^c Division of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA

Address reprint requests to Dr del Nido, Department of Cardiac Surgery, Children’s Hospital, 300 Longwood Ave, Boston, MA 02115;
e-mail: delnido{at}a1.tch.harvard.edu

Background. Prolonged ischemia and inadequate myocardial preservation remain significant perioperative risk factors in cardiac transplantation. Long-term preservation techniques that have been effective in small rodent hearts have not been as effective in larger animal models or in clinical studies. We developed a cardioplegia solution formulated to promote high-energy phosphate production from glycolysis and determined its efficacy in a blood perfused canine heart model subjected to 24 hours of ischemia.

Methods. Hearts harvested from adult dogs (n = 6 per group) were flushed with a histidine-buffered cardioplegia solution containing glucose or University of Wisconsin solution. The hearts were maintained at 4°C for 24 hours then reperfused with autologous blood. After reperfusion, left ventricular pressures were measured with an intracavitary balloon at varying balloon volumes and compared with control nonischemic hearts. Predicted stroke volume and ejection fraction were calculated at an end-systolic pressure of 70 mm Hg and end-diastolic pressure of 15 mm Hg.

Results. Developed pressure was better preserved in the hearts that received histidine-buffered solution (93 ± 9 versus 38 ± 7 mm Hg, p < 0.05), along with a higher end-diastolic volume at 15 mm Hg (31 ± 3 versus 22 ± 2 mL histidine-buffered versus University of Wisconsin solutions, respectively, p < 0.05). Stroke volume and ejection fraction were also higher in the histidine group (17 ± 2.5 versus 2.3 ± 1.2 mL and 50% ± 3.5% versus 9% ± 4.5%, respectively) in the presence of dobutamine.

Conclusions. The highly buffered glycolysis-promoting cardioplegia solution provided effective preservation of the blood perfused canine heart with superior recovery of pump performance after 24 hours of hypothermic ischemia compared with University of Wisconsin solution in this model.

This article has been cited by other articles:

				G. J. Harrison, M. H. van Wijhe, B. de Groot, F. J. Dijk, L. A. Gustafson, and J. H. G. M. van Beek Glycolytic buffering affects cardiac bioenergetic signaling and contractile reserve similar to creatine kinase Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H883 - H890. [Abstract] [Full Text] [PDF]

				E. M. Hoenicke, X. Sun, R. G. Strange Jr, and R. J. Damiano Jr Donor heart preservation with a novel hyperpolarizing solution: Superior protection compared with University of Wisconsin solution J. Thorac. Cardiovasc. Surg., October 1, 2000; 120(4): 746 - 754. [Abstract] [Full Text] [PDF]